Back
Salarius Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
SLRX
Salarius Pharmaceuticals
Last Price:
$0.77
Seasonality Move:
-22.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLRX is experiencing selling pressure, which indicates risk of future bearish movement.
Salarius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.79 | Sell |
| 20-day SMA: | 0.78 | Sell |
| 50-day SMA: | 0.76 | Buy |
| 200-day SMA: | 1.41 | Sell |
| 8-day EMA: | 0.79 | Sell |
| 20-day EMA: | 0.78 | Sell |
| 50-day EMA: | 0.86 | Sell |
| 200-day EMA: | 1.75 | Sell |
Salarius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 46.98 | Sell |
| Chaikin Money Flow: | -29601 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.72 - 0.82) | Sell |
| Bollinger Bands (100): | (0.57 - 1.93) | Sell |
Salarius Pharmaceuticals Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Salarius Pharmaceuticals Stock
Is Salarius Pharmaceuticals Stock a Buy?
-
Salarius Pharmaceuticals share price is 0.76 while SLRX 8-day simple moving average is 0.79, which is a Sell signal.
-
The stock price of SLRX is 0.76 while Salarius Pharmaceuticals 20-day SMA is 0.78, which makes it a Sell.
-
Salarius Pharmaceuticals 50-day simple moving average is 0.76 while SLRX share price is 0.76, making it a Buy technically.
-
SLRX stock price is 0.76 and Salarius Pharmaceuticals 200-day simple moving average is 1.41, creating a Sell signal.
SLRX Technical Analysis vs Fundamental Analysis
Sell
28
Salarius Pharmaceuticals (SLRX)
is a Sell
Is Salarius Pharmaceuticals a Buy or a Sell?
-
Salarius Pharmaceuticals stock is rated a SellThe current Salarius Pharmaceuticals [SLRX] share price is $0.76. The Score for SLRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Salarius Pharmaceuticals Stock Info
Market Cap:
1.6M
Price in USD:
0.76
Share Volume:
29.6K
Salarius Pharmaceuticals 52-Week Range
52-Week High:
7.20
52-Week Low:
0.45
Sell
28
Salarius Pharmaceuticals (SLRX)
is a Sell
Salarius Pharmaceuticals Share Price Forecast
-
What is the Salarius Pharmaceuticals stock price today?The Salarius Pharmaceuticals stock price is 0.76 USD today.
-
Will SLRX stock go up or go down?Salarius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Salarius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Salarius Pharmaceuticals is overvalued.
Is Salarius Pharmaceuticals Stock a Buy?
-
Salarius Pharmaceuticals share price is 0.76 while SLRX 8-day exponential moving average is 0.79, which is a Sell signal.
-
The stock price of SLRX is 0.76 while Salarius Pharmaceuticals 20-day EMA is 0.78, which makes it a Sell.
-
Salarius Pharmaceuticals 50-day exponential moving average is 0.86 while SLRX share price is 0.76, making it a Sell technically.
-
SLRX stock price is 0.76 and Salarius Pharmaceuticals 200-day simple moving average is 1.75, creating a Sell signal.
Fundamental Analysis of Salarius Pharmaceuticals
Is Salarius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $6.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $26.64 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Salarius Pharmaceuticals
Should I short Salarius Pharmaceuticals stock?
-
SLRX Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Salarius Pharmaceuticals is a Buy
-
Salarius Pharmaceuticals Relative Strength Index (RSI) is 46.98, which suggest Salarius Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Salarius Pharmaceuticals is (0.72 - 0.82), which suggest Salarius Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Salarius Pharmaceuticals is (0.57 - 1.93), which suggest Salarius Pharmaceuticals is a Sell
* Salarius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.